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have fly homologs that are specifically
expressed in larval oenocytes. Nota-
bly, this list includes the fly orthologs
of the mammalian Hnf4 and COUP-TF
genes, which encode nuclear recep-
tors involved in hepatocyte differentia-
tion. Further functional studies will be
necessary to explore the role of these
oenocyte-specific genes in controlling
general lipid metabolism. The authors
have already taken a step toward
achieving this long-term goal with the
functional characterization of Cyp4g1,
an oenocyte-specific gene that
encodes a microsomal lipid u-hydro-
lase. Animals mutant for Cyp4g1 ex-
hibit pupal lethality and an improper
oleic/stearic acid ratio in their TAG
content, indicating that this oenocyte-
specific enzyme controls the fatty-
acid composition of lipid stores.
Several lines of future research have
now been opened up by this study:
One should now be able to unravel
the essential steps of lipid metabolism
that take place in larval oenocytes and,
specifically, the role that oenocytes
play in the production of ketone bodies
during starvation. Interestingly, earlier
studies reported that ketone bodies
are found in hemolymph, fat, and
muscles and that several enzymes
involved in ketogenesis are found in
the fat bodies of insects, suggesting
possible complementary functions
between oenocytes and fat cells in
ketogenesis (Downer, 1985). Another
exciting line of research concerns the
nature of the crosstalk between oeno-
cytes and fat cells in processing lipid
stores. The nice in vivo work by
Gutierrez et al. (2007) demonstrates
the existence of an unknown feedback
mechanism through which hepato-
cyte-like cells can control lipolysis in
fat cells. Recent evidence from mam-
mals suggests that such feedback,
from liver to adipose tissue, via angio-
poietin-like proteins (Angptl), may play
an important role in the pathogenesis
of the metabolic syndrome (Oike
et al., 2005). Finally, as several fly ge-
netic backgrounds produce abnormal
oenocyte steatosis under fed condi-
tions, it may be possible to use Dro-
sophila to model some of the underly-
ing causes of human fatty liver
disease. Together, these exciting new
lines of research in flies promise to
provide an interesting paradigm to un-
derstand both normal and pathologi-
cal relationships between fat and
liver-like cells in a genetically tractable
model.
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GCN2 is a sensor of amino acid deprivation that triggers a repression of global protein synthesis while
simultaneously inducing translation of specific proteins. In this issue of Cell Metabolism, Guo and
Cavener (2007) present a much broader role for GCN2 in controlling lipid homeostasis in response
to amino acid deprivation.During times of energy deprivation,
mammals undergo a complex series
of metabolic responses designed to
enhance survival (Finn and Dice,
2006). One aspect of this response is
the utilization of triglyceride stores, pri-marily from adipose tissue, to provide
energy in the form of fatty acids and
ketone bodies. At the same time, pro-
tein degradation rates are increased
to provide amino acid precursors.
While these can be used as gluconeo-Cell Metabolismgenic precursors, they also provide for
the continued availability of essential
amino acids. These building blocks
are critical for the synthesis of a subset
of proteins that act to withstand the
rigors of energy deprivation. Coupled5, February 2007 ª2007 Elsevier Inc. 85
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Previewswith the increased break-
down of lipid stores and
proteins, the general bio-
synthetic pathways of all
macromolecules are re-
duced to conserve energy.
The pathways that regu-
late lipid balance during en-
ergy deprivation are
relatively well understood.
Generally, these pathways
lead to transcriptional re-
programming of major met-
abolic tissues in response
to hormonal and humeral
signals of energy depriva-
tion. In the liver, this re-
programming results in
enhanced glycogenolysis,
gluconeogenesis, fatty-acid
oxidation, and ketone-body
formation. The responses
of organisms and cells to
amino acid deprivation have
also been well character-
ized. However, the path-
ways regulating lipid and
amino acid homeostasis
had been thought to be
largely distinct. Recent work from the
Cavener lab, however, demonstrates
that the key metabolic regulator
GCN2 functions to coordinately regu-
late both protein synthesis and lipid
metabolism during periods of amino
acid starvation (Guo and Cavener,
2007).
GCN2 was first identified in yeast
as a critical regulator of cellular re-
sponses to amino acid starvation (Hin-
nebusch, 2005). GCN2, a protein ki-
nase whose only known target is the
translation initiation factor eIF2a, be-
longs to a family of protein kinases
that phosphorylate a specific residue
of eIF2a in response to various
stresses to modulate protein synthesis
(Harding et al., 2003; Wek et al., 2006).
GCN2 is activated by direct binding of
uncharged tRNAs that accumulate
during amino acid limitation. Hence,
GCN2 serves as a sensor of amino
acid deprivation and can detect limita-
tion of even a single amino acid. Phos-
phorylation of eIF2a leads to the inhibi-
tion of translation initiation of most
cellular proteins and a global reduction
in protein synthesis. Hence, GCN2 en-
sures that all amino acids are avail-
able to support cell growth and func-
tion. Translation of a small subset of
mRNAs, however, is activated by the
same eIF2a modification. In yeast,
translation of the transcription factor
GCN4 is activated; GCN4 subse-
quently increases expression of a fam-
ily of gene products, including all
amino acid biosynthetic enzymes,
that allow the yeast to withstand the
lack of amino acids (Hinnebusch,
2005). This system thereby ensures
an adequate supply of amino acid pre-
cursors to maintain critical protein syn-
thesis during times of stress induced
by amino acid limitation.
Similarly to yeast, mammals also
display a characteristic adaptation to
amino acid starvation (Kilberg et al.,
2005). This adaptation includes in-
creased synthesis of amino acid bio-
synthetic enzymes and amino acid
transporters coupled with a reduction
in global protein synthesis. The mam-
malian GCN2 ortholog (Berlanga
et al., 1999) mediates this response to
amino acid starvation. Mice deleted
for the Gcn2 gene exhibit a phenotype
comparable to yeast gcn2 mutants
(Anthony et al., 2004; Zhang et al.,
2002). The GCN2-deleted
mice are viable and appear
normal when maintained
on a balanced diet, but fetal
development is impaired if
diets are limited for an es-
sential amino acid. Cells
that are null for GCN2 fail
to increase phosphorylation
of eIF2a in response to
amino acid deprivation.
While the role of mamma-
lian GCN2 in altering the
protein synthetic program
in amino acid-starved cells
is well established, Guo
and Cavener (2007) asked
whether its role is potentially
broader. In nature, the ab-
sence of amino acids in the
diet is very likely to occur
at times of more general en-
ergy deprivation. Could
GCN2 also play a more ex-
pansive role as a central
regulator of other path-
ways?
Guo and Cavener (2007)
examined the effects of
a diet depleted for a single amino
acid on lipid metabolism. They found
that mice on such a diet exhibited re-
pressed triglyceride synthesis in the
liver, coupled with an enhanced mobi-
lization of triglycerides from adipose
stores (Figure 1). However, GCN2-de-
leted mice on the amino acid-depleted
diet displayed a paradoxical increase
in liver lipogenesis, with ensuing liver
steatosis. Lipid mobilization from adi-
pose tissue was reduced in these ani-
mals. The accumulation of triglyceride
in the liver correlated with a failure to
repress SREBP-1c in the knockout an-
imals, as was observed in wild-type lit-
termates. This failure to suppress
SREBP-1c, a key transcriptional acti-
vator of the de novo lipogenic path-
way, led to elevated levels of several
key lipogenic enzymes, notably fatty
acid synthase. These results are con-
sistent with in vitro studies showing
that leucine deprivation represses
fatty-acid synthesis in HepG2 cells
(Dudek and Semenkovich, 1995).
Hence, limitation of even a single
amino acid can trigger a global re-
sponse that includes modulation of
lipid synthesis.
Figure 1. Schematic Depicting the GCN2 Pathway and Its
Influence on Lipogenesis
Lines ending in arrows indicate processes that are activated; lines
ending in bars indicate processes that are repressed. The dotted line
indicates a process for which the molecular mechanism is unknown.86 Cell Metabolism 5, February 2007 ª2007 Elsevier Inc.
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eral interesting implications. They
demonstrate a coordinate regulation
of metabolic adaptation to amino
acid starvation that impacts not only
protein biosynthetic pathways but
also lipid metabolism. They also
strongly implicate GCN2 as a major
mediator of nutrient sensing via its
ability to detect uncharged tRNAs.
This coupling of pathways provides
for a coordinated response of the or-
ganism to conditions of amino acid
limitation.
Naturally, these surprising observa-
tions raise many questions. Most nota-
bly, what is the molecular pathway by
which GCN2 activation leads to the
repression of hepatic lipogenesis and
mobilization of adipose triglycerides?
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Glycerol-3-phosphate acyltransfe
lipids and, in the process, regula
lular signaling molecules. The rec
a role for GPAT isoforms in nutrie
In the pathways of carbohydrate,
amino acid, and protein synthesis, it
is rare to find that more than a single
enzyme catalyzes a specific reaction;
with complex lipid synthesis, however,
the reverse is true. For example, in the
pathway of glycerolipid synthesis out-
lined in the 1950s and 60s by Eugene
Kennedy and colleagues (Kennedy,
1957), every step is catalyzed by two
or more isoforms, each encoded by
a separate gene (Figure 1). Although
the most prominent isoforms may dif-
fer across tissues, most tissues ex-
press at least two of these isoforms.
With the exception of lipin, each en-
zyme in this pathway is an intrinsicof selected mRNAs, a simple model
would be that GCN2 enhances expres-
sion of a repressor of Srebp-1c gene
expression. Another question is
whether the actions of GCN2 on adi-
pose tissue lipolysis are direct or are
a consequence of metabolic signals
from the liver. It will be interesting to
see how this pathway unravels in fur-
ther extending our understanding of
metabolic adaptations to nutritional
stresses.
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membrane protein containing trans-
membranedomains and long stretches
of hydrophobic amino acids that prob-
ably interact closely with both their hy-
drophobic substrates and the mem-
brane surface. Despite the fact that
the catalytic site of each enzyme
involved in triacylglycerol (TAG) syn-
thesis faces the cytosol, evidence sug-
gests that the lipid intermediates lyso-
phosphatidic acid (LPA), phosphatidic
acid (PA), and diacylglycerol (DAG) are
present in nonmingling pools.
The committed step in the synthesis
of TAG is glycerol-3-phosphate acyl-
transferase (GPAT), which has tradi-
tionally been believed to exist in every
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is of triacylglycerol and phospho-
etabolites known to be intracel-
soform (Cao et al., 2006) suggests
cell as two major isoforms, one in the
endoplasmic reticulum (ER) and one
on the mitochondrial outer membrane.
In addition to their subcellular loca-
tions, these GPAT isoforms were
differentiated by their varying suscep-
tibility to inhibition by sulfhydryl
reagents like N-ethylmaleimide and
their different preferences for satu-
rated and unsaturated long-chain fatty
acyl-CoAs. This picture has now been
modified by the recognition that at
least three GPAT isoforms are present
in most tissues. These include two
mitochondrial GPATs (Gonzalez-Baro´
et al., 2007; Lewin et al., 2004) and a
recently cloned ER GPAT (Cao et al.,
5, February 2007 ª2007 Elsevier Inc. 87
